Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Aug 21, 2023 12:53pm
218 Views
Post# 35598091

RE:Next week's trial result update

RE:Next week's trial result updateIt looks like we are headed for a 450 day CR rate of around 40% in 6 months. Is it possible Theralase is waiting for this result before submitting their BTD application - so as to remove all doubt about durable complete response? 

Eoganacht wrote: Next week we should get an update on the trial results. The last one we got was on May 30 and looked like this:

CR 90 days CR 180 days CR 270 days CR 360 days
60% 53% 43% 36%
32 out of 53 26 out of 49 18 out of 42 14 out of 39

The CR rate at 450 days (33%) won't likely change as there weren't any patients diplayed on the swimmer's plot at 360 days waiting for their 450 day evaluation. Here is the best case scenario we could see next week. This assumes that all of the 5 patients waiting for their 90 day evaluation are CR.

CR 90 days CR 180 days CR 270 days CR 360 days
64% 53% 49% 38%
37 out of 58 28 out of 53 24 out of 49 16 out of 42

We will have to wait a while to see a big improvement in the 450 day results: The May 30 results looked like this:

CR 450 days
33%
13 out of 39


In 6 months, if all goes well. the 450 day results could look like this:

CR 450 days
41%
20 out of 49



<< Previous
Bullboard Posts
Next >>